Systematic review of the staging performance of 18F- fluorodeoxyglucose positron emission tomography in esophageal cancer

Journal of Clinical Oncology

Volumn 22, Issue 18, 2004, Pages 3805-3812

  Van Westreenen, H L ^a   Westerterp, M ^a   Bossuyt, P M M ^a   Pruim, J ^a   Sloof, G W ^a   Van Lanschot, J J B ^a   Groen, H ^a   Plukker, J Th M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CANCER STAGING; DIAGNOSTIC ACCURACY; ESOPHAGUS CANCER; HUMAN; LYMPH NODE METASTASIS; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESOPHAGUS TUMOR; METHODOLOGY; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

CLINICAL TRIALS; ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 4644236287     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.083     Document Type: Review

References (59)

1. Pera M, Pera M: Recent changes in the epidemiology of esophageal cancer. Surg Oncol 10:81-90, 2001
2. Hulscher JB, Tijssen JG, Obertop H, et al: Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 72:306-313, 2001
3. Ellis FH Jr, Heatley GJ, Krasna MJ, et al: Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 113: 836-846, 1997
4. Parshad R, Singh RK, Kumar A, et al: Adenocarcinoma of distal esophagus and gastroesophageal junction: Long-term results of surgical treatment in a North Indian Center. World J Surg 23:277-283, 1999
5. Sariego J, Mosher S, Byrd M, et al: Prediction of outcome in "resectable" esophageal carcinoma. J Surg Oncol 54:223-225, 1993
6. Shao LF, Gao ZG, Yang NP, et al: Results of surgical treatment in 6,123 cases of carcinoma of the esophagus and gastric cardia. J Surg Oncol 42:170-174, 1989
7. Kelly S, Harris KM, Berry E, et al: A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49:534-539, 2001
8. Reed CE, Mishra G, Sahai AV, et al: Esophageal cancer staging: Improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 67:319-321, 1999
9. Romagnuolo J, Scott J, Hawes RH, et al: Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc 55:648-654, 2002
10. Thompson WM, Halvorsen RA Jr: Staging esophageal carcinoma II: CT and MRI. Semin Oncol 21:447-152, 1994
11. Czernin J, Phelps ME: Positron emission tomography scanning: Current and future applications. Annu Rev Med 53:89-112, 2002
12. Gambhir SS, Czernin J, Schwimmer J, et al: A tabulated summary of the FDG PET literature. J Nucl Med 42:1S-93S, 2001
13. Brown RS, Leung JY, Fisher SJ, et al: Intratumoral distribution of tritiated-FDG in breast carcinoma: Correlation between Glut-1 expression and FDG uptake. J Nucl Med 37: 1042-1047, 1996
14. Lowe VJ, Naunheim KS: Current role of positron emission tomography in thoracic oncology. Thorax 53:703-712, 1998
15. Yasuda S, Raja S, Hubner KF: Application of whole-body positron emission tomography in the imaging of esophageal cancer: Report of a case. Surg Today 25:261-264, 1995
16. Deville WL, Buntinx F, Bouter LM, et al: Conducting systematic reviews of diagnostic studies: Didactic guidelines. BMC Med Res Methodol 2:9, 2002
17. Deville WL, van der Windt DA, Dzaferagic A, et al: The test of Lasegue: Systematic review of the accuracy in diagnosing herniated discs. Spine 25:1140-1147, 2000
18. Mijnhout GS, Hoekstra OS, van Tulder MW, et al: Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients. Cancer 91:1530-1542, 2001
19. Cochrane Methods Working Group on Systematic Review of Screening and Diagnostic Tests: Recommended Methods, updated June 6, 1996. http://www.cochrane.org/cochrane/sadtdoc1.htm
20. Brennan P, Silman A: Statistical methods for assessing observer variablility in clinical measures. BMJ 304:1491-1494, 1992
21. Sobin LH, Wittekind C: TNM Classification of Malignant Tumours, 6th Edition. New York, NY, John Wiley and Sons, 2003
22. Van Houwelingen HC, Zwinderman KH, Stijnen T: A bivariate approach to meta-analysis. Stat Med 12:2273-2284, 1993
23. Deeks JJ: Systematic reviews of evaluations of diagnostic and screening tests, in Egger M, Davey Smith G, Altman DG (ed): Systematic Reviews in Health Care: Meta-Analysis in Context (2nd ed). London, England, BMJ Books, 2001
24. Flanagan FL, Dehdashti F, Siegel BA, et al: Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168:417-124, 1997
25. Lerut T, Flamen P, Ectors N, et al: Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232:743-752, 2000
26. Luketich JD, Schauer PR, Meltzer CC, et al: Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64:765-769, 1997
27. Luketich JD, Friedman DM, Weigel TL, et al: Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 68:1133-1137, 1999
28. Himeno S, Yasuda S, Shimada H, et al: Evaluation of esophageal cancer by positron emission tomography. Jpn J Clin Oncol 32:340-346, 2002
29. Kim K, Park SJ, Kim BT, et al: Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 71:290-294, 2001
30. McAteer D, Wallis F, Couper G, et al: Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol 72:525-529, 1999
31. Skehan SJ, Brown AL, Thompson M, et al: Imaging features of primary and recurrent esophageal cancer at FDG PET. Radiographics 20:713-723, 2000
32. Yeung HWD, Macapinlac HA, Mazumdar M, et al: FDG-PET in esophageal cancer: Incremental value over computed tomography. Clinical Positron Imaging 2:255-260, 1999
33. Block MI, Patterson GA, Sundaresan RS, et al: Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64:770-776, 1997
34. Kole AC, Plukker JT, Nieweg OE, et al: Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 78:521-527, 1998
35. Rankin SC, Taylor H, Cook GJ, et al: Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 53:659-665, 1998
36. Kobori O, Kirihara Y, Kosaka N, et al: Positron emission tomography of esophageal carcinoma using (11)C- choline and (18)F-fluorodeoxyglucose: A novel method of preoperative lymph node staging. Cancer 86:1638-1648, 1999
37. Kato H, Kuwano H, Nakajima M, et al: Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 94:921-928, 2002
38. Choi JY, Lee KH, Shim YM, et al: Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 41:808-815, 2000
39. Junginger T, Kneist W, Schreckenberger M, et al: Positronen-Emissions- Tomographie zum präoperativen Staging des Ösophaguskarzinoms. Dtsch Med Wochenschr 127:1935-1941, 2003
40. Wren SM, Stijns P, Srinivas S: Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 137:1001-1006, 2002
41. Meltzer CC, Luketich JD, Friedman D, et al: Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 25:882-887, 2000
42. Flamen P, Lerut A, Van Cutsem E, et al: Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18:3202-3210, 2000
43. Jager PL, Que TH, Vaalburg W, et al: Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med 28:1845-1849, 2001
44. Yoon YC, Lee KS, Shim YM, et al: Metastasis to Regional Lymph Nodes in Patients with Esophageal Sqaumous Cell Carcinoma: CT versus FDG PET for Presurgical Detection-Prospective Study. Radiology 227:764-770, 2003
45. Irwig L, Tosteson AN, Gatsonis C, et al: Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120:667-676, 1994
46. Vroomen P, de Krom M, Knottnerus J: Diagnostic value of history and physical examination in patients suspected of sciatica due to disc herniation: A systematic review. J Neurol 246:899-906, 1999
47. Lachs M, Nachamkin I, Edelstein P, et al: Spectrum bias in the evaluation of diagnostic tests: Lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med 117:135-140, 1992
48. Bossuyt PM, Reitsma JB, Bruns DE, et al: The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration. Clin Chem 49:7-18, 2003
49. Strauss LG: Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 23:1409-1415, 1996
50. Van Westreenen HL, Heeren PA, Jager PL, et al: Pitfalls of positive findings in staging esophageal cancer with f-18-fluorodeoxyglucose positron emission tomography. Ann Surg Oncol 10:1100-1105, 2003
51. Rice TW: Clinical staging of esophageal carcinoma: CT, EUS, and PET. Chest Surg Clin N Am 10:471-485, 2000
52. Wakelin SJ, Deans C, Crofts TJ, et al: A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol 41: 161-167, 2002
53. Lightdale CJ: Esophageal cancer: American College of Gastroenterology. Am J Gastroenterol 94:20-29, 1999
54. Hulscher JB, Buskens CJ, Bergman JJ, et al: Positive peritruncal nodes for esophageal carcinoma: Not always a dismal prognosis. Dig Surg 18:98-101, 2001
55. Eloubeidi MA, Wallace MB, Hoffman BJ, et al: Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: Impact of staging endosonography. Ann Thorac Surg 72:212-219, 2001
56. Eloubeidi MA, Wallace MB, Reed CE, et al: The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: A single-center experience. Gastrointest Endosc 54:714-719, 2001
57. Parmar KS, Zwischenberger JB, Reeves AL, et al: Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer. Ann Thorac Surg 73:916-920, 2002
58. Reed CE, Eloubeidi MA: New techniques for staging esophageal cancer. Surg Clin North Am 82:697-710, 2002
59. Wallace MB, Nietert PJ, Earle C, et al: An analysis of multiple staging management strategies for carcinoma of the esophagus: Computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/ laparoscopy. Ann Thorac Surg 74:1026-1032, 2002